HIV/AIDS

  1. Changes in Sexual Behavior, PrEP Adherence, and Access to Sexual Health Services Because of the COVID-19 Pandemic Among a Cohort of PrEP-Using MSM in the South

    1. Sanjana Pampati
    2. Kayla Emrick
    3. Aaron J. Siegler
    4. Jeb Jones

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Incidence of and factors associated with SARS‐CoV‐2 infection among people living with HIV in Southern Spain after one year of pandemic

    1. Marta Fernandez‐Fuertes
    2. Anaïs Corma‐Gomez
    3. Eva Torres
    4. Elena Rodriguez‐Pineda
    5. Ana Fuentes‐Lopez
    6. Pilar Rincon
    7. Nieves Fernandez
    8. Federico Garcia
    9. Samuel Bernal
    10. Luis M. Real
    11. Juan Macias
    12. Juan A. Pineda

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Changes in HIV treatment differentiated care uptake during the COVID‐19 pandemic in Zambia: interrupted time series analysis

    1. Youngji Jo
    2. Sydney Rosen
    3. Karla Therese L. Sy
    4. Bevis Phiri
    5. Amy N. Huber
    6. Muya Mwansa
    7. Hilda Shakwelele
    8. Prudence Haimbe
    9. Mpande M. Mwenechanya
    10. Priscilla Lumano‐Mulenga
    11. Brooke E. Nichols

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Association of HIV infection with outcomes among adults hospitalized with COVID-19

    1. Matthew S. Durstenfeld
    2. Kaiwen Sun
    3. Yifei Ma
    4. Fatima Rodriguez
    5. Eric A. Secemsky
    6. Rushi V. Parikh
    7. Priscilla Y. Hsue

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. The impact of disruptions due to COVID‐19 on HIV transmission and control among men who have sex with men in China

    1. Ross D Booton
    2. Gengfeng Fu
    3. Louis MacGregor
    4. Jianjun Li
    5. Jason J Ong
    6. Joseph D Tucker
    7. Katherine ME Turner
    8. Weiming Tang
    9. Peter Vickerman
    10. Kate M Mitchell

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Knowledge and Impact of COVID-19 on Middle-Aged and Older People living with HIV in Lima, Peru

    1. Monica M. Diaz
    2. Diego M. Cabrera
    3. Marcela Gil-Zacarías
    4. Valeria Ramírez
    5. Manuel Saavedra
    6. Cesar Cárcamo
    7. Evelyn Hsieh
    8. Patricia J. García

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. The risks and benefits of providing HIV services during the COVID-19 pandemic

    1. John Stover
    2. Sherrie L. Kelly
    3. Edinah Mudimu
    4. Dylan Green
    5. Tyler Smith
    6. Isaac Taramusi
    7. Loveleen Bansi-Matharu
    8. Rowan Martin-Hughes
    9. Andrew N. Phillips
    10. Anna Bershteyn

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy

    1. Alexander O Pasternak
    2. Jelmer Vroom
    3. Neeltje A Kootstra
    4. Ferdinand WNM Wit
    5. Marijn de Bruin
    6. Davide De Francesco
    7. Margreet Bakker
    8. Caroline A Sabin
    9. Alan Winston
    10. Jan M Prins
    11. Peter Reiss
    12. Ben Berkhout
    13. The Co-morBidity in Relation to Aids (COBRA) Collaboration
    14. P Reiss
    15. FWNM Wit
    16. J Schouten
    17. KW Kooij
    18. RA van Zoest
    19. BC Elsenga
    20. FR Janssen
    21. M Heidenrijk
    22. W Zikkenheiner
    23. M van der Valk
    24. NA Kootstra
    25. T Booiman
    26. AM Harskamp-Holwerda
    27. I Maurer
    28. MM Mangas Ruiz
    29. AF Girigorie
    30. J Villaudy
    31. E Frankin
    32. AO Pasternak
    33. B Berkhout
    34. T van der Kuyl
    35. P Portegies
    36. BA Schmand
    37. GJ Geurtsen
    38. JA ter Stege
    39. M Klein Twennaar
    40. CBLM Majoie
    41. MWA Caan
    42. T Su
    43. K Weijer
    44. PHLT Bisschop
    45. A Kalsbeek
    46. M Wezel
    47. I Visser
    48. HG Ruhé
    49. C Franceschi
    50. P Garagnani
    51. C Pirazzini
    52. M Capri
    53. F Dall'Olio
    54. M Chiricolo
    55. S Salvioli
    56. J Hoeijmakers
    57. J Pothof
    58. M Prins
    59. M Martens
    60. S Moll
    61. J Berkel
    62. M Totté
    63. S Kovalev
    64. M Gisslén
    65. D Fuchs
    66. H Zetterberg
    67. A Winston
    68. J Underwood
    69. L McDonald
    70. M Stott
    71. K Legg
    72. A Lovell
    73. O Erlwein
    74. N Doyle
    75. C Kingsley
    76. DJ Sharp
    77. R Leech
    78. JH Cole
    79. S Zaheri
    80. MMJ Hillebregt
    81. YMC Ruijs
    82. DP Benschop
    83. D Burger
    84. M de Graaff-Teulen
    85. G Guaraldi
    86. A Bürkle
    87. T Sindlinger
    88. M Moreno-Villanueva
    89. A Keller
    90. C Sabin
    91. D de Francesco
    92. C Libert
    93. S Dewaele

    • Curated by eLife

      Evaluation Summary:

      This study addresses how antiviral treatment regimens impact persistence of an HIV reservoir in individuals who are treated for a long period. The authors examine measures of viral reservoir to understand how different antiviral treatment regimens impact residual virus in HIV infection. They find that NNRTI-based treatments are associated with lower viral reservoirs and better viral suppression than PI-based regimens, suggesting they may have some advantage at reducing HIV levels long term.

      (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 agreed to share their name with the authors.)

    Reviewed by eLife

    4 evaluationsAppears in 1 listLatest version Latest activity
Previous Page 7 of 7